Thermo Fisher's Q3 numbers just dropped, and while revenue hit $10.60 billion (a slight uptick from Q2), it's flat compared ...

WALTHAM, Mass., November 15, 2024--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors has authorized the ...

Thermo Fisher Scientific has good revenue and margin growth prospects ahead and is trading at a discount. See why TMO stock ...

Investing.com -- Thermo Fisher Scientific Inc., a leading scientific instruments maker, reported third-quarter earnings that surpassed analyst expectations, while revenue fell slightly short of ...

Thermo Fisher Scientific Inc (NYSE:TMO), a leading player in the Life Science Tools & Diagnostics sector, has been navigating a complex market landscape characterized by both challenges and ...

Oct 23 (Reuters) - Thermo Fisher Scientific (TMO.N), opens new tab on Wednesday raised the lower end of its annual profit forecast, tweaking it for the third time this year, betting on improved ...

Thermo Fisher Scientific posted a modest decline in third-quarter net income, but boosted the lower end of its projected range for 2024 operating earnings on steady sales of laboratory equipment.

Analyst Daniel Brennan of TD Cowen maintained a Buy rating on Thermo Fisher (TMO – Research Report), boosting the price target to $686.00. Daniel Brennan has given his Buy rating due to a ...

Thermo Fisher Scientific Inc.'s TMO third-quarter 2024 adjusted earnings per share (EPS) of $5.28 beat the Zacks Consensus Estimate by 0.6%. However, the figure decreased 7.2% year over year.